A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Newsome, MD
University of Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queens Medical Centre
Nottingham, Nottinghamshire, United Kingdom
- University Hospitals Birmingham Nhs Foundation Trust
Birmingham, West Midlands, United Kingdom
- Addenbrooke'S Hospital
Cambridge, United Kingdom
- Royal Free Hospital
London, United Kingdom
- Royal Victoria Infirmary
Newcastle, United Kingdom
- John Radcliffe Hospital
Oxford, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2015
- Primary completion
- 23 Oct 2018
- Completion
- 23 Oct 2018
- Last update posted
- 3 May 2019
- Registered enrollment
- 23
- Registry id
- NCT02239211
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.